4.6 Article

Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)

Amar Gajjar et al.

Summary: The study identified new risk stratification for medulloblastoma treatment through molecular classification and risk factor analysis, finding differences in PFS among patients with different genotypes and subtypes.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Cell Biology

Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma

Raelene Endersby et al.

Summary: The study found that CHK1/2 inhibition can enhance the cytotoxic activity of multiple chemotherapy drugs, reduce tumor burden, increase survival in medulloblastoma, and validated the clinical effectiveness in different subgroups.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Oncology

Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma A Randomized Clinical Trial From the Children's Oncology Group

Sarah E. S. Leary et al.

Summary: In a randomized clinical trial focusing on high-risk group 3 medulloblastoma, intensifying therapy with carboplatin was shown to improve 5-year event-free survival by 19%. These results highlight the importance of integrated clinical and molecular risk stratification for medulloblastoma.

JAMA ONCOLOGY (2021)

Article Oncology

Defining Optimal Target Volumes of Conformal Radiation Therapy for Diffuse Intrinsic Pontine Glioma

Christopher L. Tinkle et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

Article Clinical Neurology

Differential patterns of metastatic dissemination across medulloblastoma subgroups

Michal Zapotocky et al.

JOURNAL OF NEUROSURGERY-PEDIATRICS (2018)

Article Multidisciplinary Sciences

DNA methylation-based classification of central nervous system tumours

David Capper et al.

NATURE (2018)

Article Clinical Neurology

Risk stratification of childhood medulloblastoma in the molecular era: the current consensus

Vijay Ramaswamy et al.

ACTA NEUROPATHOLOGICA (2016)

Article Nursing

A Collaborative Step-Wise Process to Implementing an Innovative Clinic for Adult Survivors of Childhood Cancer

Wendy McClellan et al.

JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES (2015)

Article Oncology

Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma

Nataliya Zhukova et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

Article Oncology

Medulloblastoma Comprises Four Distinct Molecular Variants

Paul A. Northcott et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Multidisciplinary Sciences

Subtypes of medulloblastoma have distinct developmental origins

Paul Gibson et al.

NATURE (2010)

Article Oncology

Hyperfractionated Accelerated Radiotherapy in the Milan Strategy for Metastatic Medulloblastoma

Lorenza Gandola et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

Article Oncology

Hearing loss after radiotherapy for pediatric brain tumors: Effect of cochlear dose

Chiaho Hua et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)

Article Oncology

Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors

TE Merchant et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)